JeffreyAAlperMDCertified Principal Investigator

Clinical Trials

• A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy Start of enrollment: 2010 Oct 01

  Completed

  Phase 2

• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Start of enrollment: 2011 Jan 01

  Completed

  Phase 3

• Combining Lesinurad With Allopurinol in Inadequate Responders Start of enrollment: 2012 Jan 01

  Completed

  Phase 3

• Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat Start of enrollment: 2012 Jan 01

  Completed

  Phase 3

• A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis Start of enrollment: 2012 Jan 01

  Completed

  Phase 3

• A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) Start of enrollment: 2012 Aug 06

  Completed

  Phase 3

• A Study in Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Oct 01

  Completed

  Phase 3

• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27

  Completed

  Phase 3

• A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22

  Terminated

  Phase 2

• Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon Start of enrollment: 2016 Feb 01

  Completed

  Not Applicable

• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Start of enrollment: 2016 Aug 02

  Completed

  Phase 3

• Join now to see all